Moderna, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Moderna, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Moderna, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $14M.
  • Moderna, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$1.38B, a 60.1% increase from 2022.
  • Moderna, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$3.45B, a 295% decline from 2021.
  • Moderna, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$873M, a 143% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.38B +$2.07B +60.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 -$3.45B -$2.58B -295% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 -$873M -$2.91B -143% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-23
2020 $2.03B +$1.98B +3810% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 $52M -$1.17B -95.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $1.23B +$1.23B Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $168K* -$473M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $473M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.